What is semaglutide?
Semaglutide is a once-weekly injectable medication in the GLP-1 receptor agonist class. It mimics a natural gut hormone (glucagon-like peptide-1) that regulates appetite and blood sugar. You may know it by its brand names:
- Wegovy — FDA-approved specifically for chronic weight management
- Ozempic — FDA-approved for type 2 diabetes; widely prescribed off-label for weight loss
- Rybelsus — an oral tablet form, approved for type 2 diabetes
All three contain the same active ingredient. Which formulation is right for you depends on your medical history, insurance coverage, and goals — that’s exactly what a physician evaluation determines.
How does it work?
Semaglutide works on three fronts:
- Appetite suppression — it acts on brain centers that control hunger, so you feel full sooner and stay full longer.
- Slower digestion — food leaves the stomach more slowly, which extends satiety after meals.
- Blood sugar control — it helps the pancreas release insulin when blood sugar is high, improving metabolic health.
In clinical trials, patients on Wegovy lost an average of about 15% of body weight over 68 weeks when combined with lifestyle changes — roughly three times the weight loss seen with lifestyle changes alone.
Who is a candidate?
Semaglutide for weight management is generally considered for adults who meet criteria similar to the FDA labeling for Wegovy:
- BMI of 30 or higher, or
- BMI of 27 or higher with a weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol
It is not appropriate for everyone. People with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome, a history of pancreatitis, or certain other conditions need careful evaluation first. A physician consultation is the only way to determine candidacy safely.
What to expect: dosing and timeline
Semaglutide is a once-weekly injection you administer yourself at home — most patients find the pen device simple after a brief demonstration.
- Dose titration: treatment starts at a low dose and increases gradually over several weeks. This step-up approach is deliberate: it lets your body adjust and minimizes nausea.
- Timeline: many patients notice reduced appetite within the first few weeks; meaningful weight loss typically builds over 3–6 months.
- Duration: obesity is a chronic condition. Like blood pressure medication, GLP-1 therapy works while you take it — stopping usually leads to weight regain, which is why ongoing physician supervision matters.
Side effects
The most common side effects are gastrointestinal and usually mild-to-moderate, improving as the dose stabilizes:
- Nausea, vomiting, diarrhea, or constipation
- Decreased appetite (expected — that’s the mechanism)
- Occasional fatigue or headache
Serious but uncommon risks discussed in the FDA labeling include pancreatitis, gallbladder problems, and a boxed warning about thyroid C-cell tumors observed in rodent studies (human relevance unknown). Your physician will review your personal risk factors before prescribing and monitor you during treatment.
Our physician-led semaglutide program
At the Bariatric & Metabolic Institute, semaglutide is never handed out as a standalone prescription. Dr. Subramani’s program includes:
- Full medical evaluation — history, labs, and candidacy screening
- Personalized dosing plan — titrated to your tolerance and response
- Ongoing monitoring — follow-ups to manage side effects and adjust treatment
- Lifestyle support — nutrition and activity guidance alongside the medication
- Telemedicine follow-ups — convenient virtual visits for patients across Missouri and Illinois
Self-pay pricing: Call (573) 255-2089 for current pricing
Frequently asked questions
How is Wegovy different from Ozempic?
Same active ingredient (semaglutide), different FDA approvals and dosing. Wegovy is approved and dosed specifically for weight management; Ozempic is approved for type 2 diabetes and often used off-label for weight loss. Your physician determines which is appropriate.
Will insurance cover it?
Coverage varies widely. Many plans cover GLP-1s for diabetes but not for weight loss alone. We bill insurance where applicable and offer self-pay options — ask us for current pricing.
What happens if I stop taking it?
Clinical studies show most patients regain a significant portion of lost weight after stopping. This is why we treat obesity as a chronic condition with long-term planning, not a short course.
Can I do the program entirely by telemedicine?
If you’re in Missouri or Illinois, yes — initial evaluation and follow-ups can be done virtually. In-person visits are available at our Sikeston, MO office.
Do I need to diet and exercise too?
Medication works best combined with sustainable nutrition and activity changes. We build that into your plan rather than handing you a generic diet sheet.
This page is for educational purposes and is not medical advice. GLP-1 medications require a prescription and physician supervision. Schedule a consultation to discuss whether semaglutide is right for you: (573) 255-2089.
